The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: HSBC downgrades commercial property stocks

Mon, 10th Jul 2023 09:27

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

Numis cuts InterContinental Hotels to 'hold' - price target 5,600 pence

----------

Deutsche Bank raises Shell price target to 3,268 (2,907) pence - 'buy'

----------

Citigroup cuts Antofagasta price target to 1,500 (1,600) pence - 'neutral'

----------

Barclays cuts Endeavour Mining price target to 2,600 (3,000) pence - 'overweight'

----------

Barclays cuts Antofagasta price target to 1,270 (1,350) pence - 'equal weight'

----------

Barclays cuts Anglo American price target to 3,100 (3,300) pence - 'overweight'

----------

Citigroup cuts Anglo American price target to 3,000 (3,300) pence - 'buy'

----------

Barclays cuts Fresnillo price target to 525 (630) pence - 'equal weight'

----------

Barclays cuts Rio Tinto price target to 6,400 (6,700) pence - 'equal weight'

----------

Barclays cuts Ocado price target to 640 (740) pence - 'equal weight'

----------

Deutsche Bank raises Coca-Cola HBC target to 3,150 (2,950) pence - 'buy'

----------

Citigroup raises Coca-Cola HBC price target to 2,525 (2,425) pence - 'neutral'

----------

Citigroup cuts Vodafone price target to 73 (83) pence - 'neutral'

----------

Deutsche Bank cuts Weir Group target to 2,100 (2,135) pence - 'hold'

----------

HSBC cuts Segro to 'hold' - price target 608 pence

----------

HSBC cuts Land Securities to 'hold' - price target 485 pence

----------

Morgan Stanley cuts GSK price target to 1,440 (1,485) pence - 'equal-weight'

----------

FTSE 250

----------

HSBC cuts Safestore to 'hold' - price target 770 pence

----------

HSBC cuts Hammerson to 'reduce' - price target 12 pence

----------

HSBC cuts British Land to 'reduce' - price target 233 pence

----------

HSBC cuts Shaftesbury Capital to 'hold' - price target 121 pence

----------

HSBC cuts Great Portland Estates to 'hold' - price target 424 pence

----------

HSBC cuts Big Yellow Group to 'hold' - price target 903 pence

----------

HSBC cuts Derwent London to 'hold' - price target 2144 pence

----------

HSBC cuts Assura Group to 'hold' - price target 49 pence

----------

HSBC cuts Primary Health Properties to 'hold' - price target 102.10 pence

----------

Jefferies cuts Diversified Energy price target to 100 (110) pence - 'hold'

----------

Jefferies raises Ithaca Energy price target to 200 (195) pence - 'buy'

----------

Jefferies cuts Energean price target to 1,100 (1,215) pence - 'hold'

----------

Jefferies cuts Harbour Energy price target to 340 (360) pence - 'buy'

----------

Citigroup raises Morgan Advanced Materials target to 435 (425) pence - 'buy'

----------

RBC cuts IWG price target to 155 (190) pence - 'sector perform'

----------

RBC cuts Currys price target to 60 (70) pence - 'sector perform'

----------

Jefferies cuts Petershill Partners price target to 250 (270) pence - 'buy'

----------

JPMorgan raises Future price target to 1,900 (1,845) pence - 'overweight'

----------

JPMorgan places Ryanair and Wizz Air on 'positive catalyst watch'

----------

SMALL CAP

----------

Panmure raises IQE to 'buy' - price target 40 pence

----------

Barclays raises Wise price target to 675 (620) pence - 'equal weight'

----------

Barclays cuts South32 price target to 195 (200) pence - 'underweight'

----------

Barclays cuts Gem Diamonds price target to 24 (30) pence - 'overweight'

----------

Barclays raises BHP Group price target to 2,715 (2,625) pence - 'equal weight'

----------

Barclays reinitiates Alfa Financial Software with 'overweight' - price target 215 pence

----------

Jefferies cuts Pharos Energy price target to 26 (29) pence - 'buy'

----------

Jefferies cuts Kosmos Energy price target to 660 (750) pence - 'buy'

----------

Jefferies cuts Serica Energy price target to 290 (325) pence - 'buy'

----------

Jefferies raises Jadestone Energy price target to 54 (50) pence - 'buy'

----------

Jefferies raises EnQuest to 'buy' (hold) - price target 20 pence

----------

Jefferies raises Capricorn Energy to 'buy' (hold) - price target 225 (230) pence

----------

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.